Krispy Kreme faces growth crisis amid GLP-1 drug spread and rising debt

DNUT Krispy Kreme Inc

$3.07 +1.32%

View chart & analysis →

1. 1Recently, approximately 28 million US adults are taking GLP-1 weight loss drugs.
2. 2Purchases of sweet bakery items drop by nearly 10% after patients start taking the medication.
3. 3Krispy Kreme's debt ratio has nearly tripled since 2022.

Source Zacks +1 · View original ↗

Today's 5 AI picks, all free

Nothing hidden: past picks and how they did against the S&P 500.

See today's picks →